Subscribe to Newsletter

Bioprocessing - Upstream & Downstream

Business & Regulation Bioprocessing - Upstream & Downstream

ADC Innovation: The Road Ahead

| Rob Coker | 5 min read

ADCs have shown their promise, but the next step is realizing their potential.

Discovery & Development Bioprocessing - Upstream & Downstream

Biotech Versus the Superbugs

| 6 min read

Biotech Versus the Superbugs: Interviewing Centauri Therapeutics CSO Helen Bright

Manufacture Advanced Medicine

The Next Decade of Cell and Gene Therapies

| 5 min read

Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems; we ask experts about the future of advanced medicine.

Discovery & Development Drug Discovery

Meet the Goldilocks Molecules

| 4 min read

We get the story behind the development of Spiroligomer molecules and how they can help drug the undruggable.

Business & Regulation Profession

Sitting Down With... Moncef Slaoui

| 5 min read

The career path of Moncef Slaoui has resulted in billions of doses of lifesaving vaccines. Here he shares his story.

Manufacture Advanced Medicine

AI Approach to Transdermal GLP-1s

| 3 min read

How do you design, refine, and optimize novel GLP-1 drugs that could improve patient experiences? With a computer, of course.

Manufacture Bioprocessing - Upstream & Downstream

Irish Horizons: Sitting Down With BMS’ Karen Costello

| 4 min read

General Manager for the Irish commercial affiliate, Karen Costello, returns to her native country to help get medicines to Irish patients faster.

Manufacture Bioprocessing - Upstream & Downstream

The Era of Antibody 2.0

| 2 min read

Experts look at trends in antibody drug development, including the growing popularity of new modalities.

Manufacture Packaging

Vial Wars

| Stephanie Vine | 2 min read

Study investigates why vial choices matters for frozen biopharmaceutical storage.

Business & Regulation Bioprocessing - Upstream & Downstream

Sanofi’s Push for Pricing Flexibility in the UK

| 6 min read

We speak with Sanofi’s Anju Bhalla about its appeal against NICE’s final draft guidance for Sarclisa.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker